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Summary
Psychological/physical stresses are known to cause
relapses of autoimmune and inflammatory diseases.
To reveal a mechanism by which noninflammatory
stresses affect host defenses, responses to immobili-
zation stress in mice were investigated, focusing on
the role of a multifunctional cytokine, interleukin-18
(IL-18). In the adrenal cortex, the stress induced IL-18
precursor proteins (pro-IL-18) via adrenocorticotropic
hormone (ACTH) and a superoxide-mediated cas-
pase-1 activation pathway, resulting in conversion of
pro-IL-18 to the mature form, which was released into
plasma. Inhibitors of caspase-1, reactive oxygen spe-
cies, and P38 mitogen-activated protein kinase
(MAPK) suppressed stress-induced accumulation of
plasma IL-18. These inhibitors also blocked stress-
induced IL-6 expression. This, together with the ob-
servation that IL-6 was not induced in IL-18-deficient
mice, showed that IL-6 induction by stress is depen-
dent on IL-18. In stressed organisms, IL-18 may influ-
ence pathological and physiological processes. Con-
trolling the caspase-1 activating pathway to suppress
IL-18 levels may provide preventative means against
stress-related disruption of host defenses.
Introduction
Psychological and/or physical stresses affect host de-
fenses comprising neuronal, endocrine, and immune
systems (Dugue et al., 1993; Kiecolt-Glaser et al., 2003).
A variety of cytokines (e.g., IL-1 β, IL-6, and TNF-α) are
upregulated by stresses (Dugue et al., 1993; Mek-
aouche et al., 1994; Zhou et al., 1993), suggesting that*Correspondence: yamen@basic.med.tokushima-u.ac.jpthe cytokine may be involved in the interference with
host defenses (Schubert et al., 1999; Walker et al., 1997;
Zorzon et al., 2001). However, molecular mechanisms by
which stresses induce cytokines that impair host de-
fenses are not well understood.
IL-18 was originally discovered as an interferon-γ
(IFN-γ)-inducing factor (Okamura et al., 1995; Ushio et
al., 1996). Subsequent studies have demonstrated that
IL-18 has multiple biological activities (for review see
Dinarello et al. [1998], Nakanishi et al. [2001a], Nakani-
shi et al. [2001b], and Okamura et al. [2003]), including
induction of Fas ligand, elevation of cytolytic activity of
T cells (Nakanishi et al., 2001a), and production of Th2
cytokines (Hoshino et al., 1999; Yoshimoto et al., 2000).
IL-18 also activates Toll-like receptor 2 (TLR2; Blease et
al., 2001) and myeloid differentiation protein 88 (MyD88;
Adachi et al., 1998), which are required for induction of
IL-6 (Takeuchi et al., 2000), suggesting that IL-18 may
play a role in IL-6 expression. Thus, IL-18 is involved in
the production of both Th1 and Th2 cytokines (Hoshino
et al., 1999; Dinarello et al., 1998; Nakanishi et al.,
2001a; Nakanishi et al., 2001b; Okamura et al., 2003).
IL-18 is produced as a 24 kD precursor, which is pro-
cessed to an 18 kD mature, bioactive form by caspase-1
(IL-1β-converting enzyme, ICE, [Ghayur et al., 1997; Gu
et al., 1997]). Caspase-1 is induced in the form of an
inactive precursor, procaspase-1, which is activated by
caspase-11 (Wang et al., 1998). Caspase-11 is pro-
duced as inactive procaspase-11, which is activated by
cathepsin B (Schotte et al., 2000). Expression of cas-
pase-11 mRNA has been reported to require NF-κB
transactivation into the nucleus (Li et al., 2002; Schauv-
liege et al., 2002), which is mediated by P38 MAPK
(Vanden Berghe et al., 1998).
Conti et al. have shown that IL-18 mRNA is ex-
pressed in response to ACTH and cold stress in the
adrenal gland (Conti et al., 1997). Sugama et al. have
reported differential IL-18 promoter usage in the adre-
nal gland and immune cells with adrenal gland-specific
expression of IL-18 mRNA by ACTH, suggesting that
IL-18 may be induced in the adrenal gland during stress
(Sugama et al., 2000). They have also detected pro-IL-
18, but not mature IL-18 proteins, in the adrenal gland
and in plasma in ACTH-administrated mice. On the
other hand, plasma IL-18 levels have been reported to
be elevated in psychiatric patients (Kokai et al., 2002). It
is unclear whether psychological/physical stresses are
responsible for high levels of mature IL-18 in plasma.
In this study, the expression of IL-18 in immobiliza-
tion-stressed mice was investigated, focusing on the
processing of pro-IL-18 and the release of the mature
form into plasma. In addition, involvement of IL-18 in
the regulation of another stress-related cytokine, IL-6
(Dugue et al., 1993; Kiecolt-Glaser et al., 2003), was ex-
amined. We found that the stress caused an accumula-
tion of pro-IL-18 and induction of the P38 MAPK-cas-
pase-11-caspase-1 cascade in the adrenal gland,
leading to the processing of pro-IL-18 in the adrenal
gland and the release of mature IL-18 into plasma. We
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imice in an IL-18-dependent manner.
i
lResults
u
iPlasma IL-18 Protein Levels in Immobilization-
sStressed Mice
A
Analysis of the effect of immobilization stress on IL-18
l
expression showed that there were increases in plasma
r
IL-18 levels from 43 ± 34.3 pg/ml before the stress to
m
330 ± 64.3 and 1059 ± 30.022 pg/ml 3 and 6 hr after the
stress, respectively (Figure 1A). ACTH in plasma in-
i
creased more rapidly, reaching the maximal level (about
1
500 pg /ml) within 1 hr, but then decreased to the origi-
k
nal level at 3 hr (Figure 1A). Thus, elevation of ACTH
T
levels in plasma, which represents activation of the hy-
g
pothalamus-pituitary-adrenal (HPA) axis, preceded the
m
increase in IL-18 levels in plasma.
It has been reported that ACTH caused adrenal
gland-specific expression of IL-18 mRNA (Sugama et I
Wal., 2000). We, therefore, studied whether ACTH is in-
volved in the stress-induced elevation of plasma IL-18. c
aMice were treated with anti-ACTH antiserum or dexa-
methasone and analyzed for IL-18 levels in plasma and a
uin the adrenal gland. We found that anti-ACTH antise-
rum and dexamethasone blocked stress-induced in- i
lcreases in IL-18 levels in both plasma (Figure 1B) and
the adrenal gland (Figure 1C). In hemiadrenalectomized i
(mice, plasma IL-18 levels after stress were lower than
in sham-operated mice (data not shown). These results a
vsuggest that increases in IL-18 levels in plasma and
the adrenal gland were caused by ACTH induced by i
athe stress.Figure 1. Immobilization Stress Elevates IL-18 Levels in Plasma and the Adrenal Gland
IL-18 and ACTH levels in plasma after stress (A). Effects of anti-ACTH antibody and dexamethasone on IL-18 in plasma (B) and in the adrenal
gland (C) in stressed mice. Effects of ACTH and stress on IL-18 in plasma (D) and in the adrenal gland (E). IP-blot for IL-18 protein in the
adrenal gland and plasma (F). *p < 0.05, **p < 0.01, and ***p < 0.001 to control; #p < 0.01 to stressed; n = 4–9. Data were presented as ± SD.Next, effects of ACTH on IL-18 levels in plasma and
n the adrenal gland were investigated. ACTH admin-
stration was found to cause elevation of plasma IL-18
evels but to a much lesser extent than the stress (Fig-
re 1D). On the other hand, IL-18 in the adrenal gland
n ACTH-treated mice was elevated as much as in
tressed mice (Figure 1E). These results suggest that
CTH is primarily responsible for the elevation of IL-18
evels in the adrenal gland, but additional factors are
equired for elevating plasma IL-18 levels in stressed
ice.
Western blot analysis showed that IL-18 was present
n the form of 18 kD mature protein in plasma (Figure
F, lane 1–3), whereas it was mainly in the form of 24
D pro-IL-18 in the adrenal gland (Figure 1F, lane 4–6).
hese results suggest that pro-IL-18 in the adrenal
land is processed and released into plasma in stressed
ice.
nduction of Caspase-1 by Stress
estern blot analysis of caspase-1 showed that pro-
aspase-1 was induced by ACTH and the stress in the
drenal gland (Figure 2A). Caspase-1 activity in the
drenal gland was elevated 10-fold by the stress (Fig-
re 2B). YVAD-CHO, a caspase-1 inhibitor, effectively
nhibited the stress-induced increase in mature IL-18
evels in plasma (Figure 2C), but not in pro-IL-18 levels
n the adrenal gland (Figure 2D). In caspase-1 knockout
KO) mice, no IL-18 was detectable in plasma before
nd after the stress, although pro-IL-18 levels were ele-
ated after the stress (data not shown). These results
ndicated that the stress induced caspase-1 in the
drenal gland, which is responsible for the processing
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671Figure 2. Caspase-1 Is Essential for the
Stress-Induction of IL-18 in Plasma
Western blot of procaspase-1 in the adrenal
gland (A). Effects of stress on caspase-1 ac-
tivity in the adrenal gland (B). Effects of
YVAD-CHO on IL-18 levels in plasma (C) and
the adrenal gland (D). Effects of Z-FA-fmk on
caspase-1 activity (E) and plasma IL-18
levels (F). *p < 0.05, **p < 0.01, and ***p <
0.001 to control; #p < 0.01 to stressed; +p <
0.05 to ACTH treated; n = 4–9. Data were
presented as ± SD.of pro-IL-18 in the adrenal gland and the elevation of
IL-18 levels in plasma.
Effect of Caspase-11 Inhibition
on the Caspase-1 Activation
Because caspase-1 has been reported to be activated
by caspase-11 (Wang et al., 1998), and caspase-11 ac-
tivation requires cathepsin-B (Schotte et al., 2000), the
effect of the cathepsin-B inhibitor Z-FA-fmk and anti-
caspase-11 antibody on caspase-1 activity in the adre-
nal gland and IL-18 levels in plasma was investigated.
The results showed that both of them suppressed
stress-induced increases in caspase-1 activity in the
adrenal gland (Figure 2E) and IL-18 levels in plasma
(Figure 2F), whereas controls (e.g., control IgG) did not,
indicating that caspase-11 is involved in the stress-
induced activation of caspase-1 in the adrenal gland.
Effect of P38 MAPK Inhibition
on the Caspase-1 Activation
It has been shown that SB203580, a P38 MAPK inhibi-
tor, suppresses induction of caspase-11 in C6 glioma
cells in vitro (Hur et al., 2001). We examined whether
caspase-11 induction in the adrenal gland is mediated
by P38 MAPK by using another P38 MAPK inhibitor,
SB202190, reported to be more specific than SB203580
and anti-phosphorylated P38 MAPK antibody. We
found that SB202190 inhibited the stress-induced in-crease in procaspase-11 levels (Figure 3A), caspase-1
activity in the adrenal gland (Figure 3B), and IL-18 levels
in plasma (Figure 3C). Similar inhibition was observed
with anti-phosphorylated P38 MAPK antibody, whereas
no inhibition was seen with IgG used as a control (Fig-
ures 3A–3C). PD 98059, a mitogen-activated protein ki-
nase/extracellular signal-regulated kinase (MEK/ERK)
inhibitor did not significantly affect P38 MAPK phos-
phorylation (data not shown) and caspase-11 induction
(Figure 3A). Neither YVAD-CHO nor Z-FA-fmk affected
phosphorylation of P38 MAPK in the adrenal gland (Fig-
ure 3D). Phosphorylation of P38 MAPK was induced by
the stress in caspase-1 KO mice (Figure 3D, lane 5) as
in wild-type (wt) mice (Figure 3D, lane 2), indicating that
the phosphorylation of P38 MAPK was independent of
caspase-1.
We conducted immunohistochemical localization of
IL-18, caspase-1, caspase-11, and activated P38 MAPK
in the adrenal gland. In stressed mice, these proteins
were colocalized in the zona reticularis of the adrenal
cortex (Figure 3E), but in control mice, none of them
was detected (data not shown). The inhibitors of cas-
pase-1 (Figure 3F, panel 1), caspase-11 (Figure 3F, panel
2), and anti-caspase-11 antibody (data not shown) had
no effect on the accumulation of phosphorylated P38
MAPK in the adrenal cortex. These results suggested
that P38 MAPK is involved in stress-induced elevation
of plasma IL-18 levels, possibly via induction of cas-
pase-11, which in turn activates caspase-1.
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672Figure 3. Caspase-1 Activation Is Suppressed by P38 MAPK Inhibitors
Effects of P38 MAPK inhibition on the expression of 43 kD caspase-11 precursor (A). Effect of P38 MAPK inhibition on caspase-1 activity (B)
and plasma IL-18 levels (C). P38 MAPK inhibitors and Z-FA-fmk, a caspase-11 inhibitor, suppressed both levels. IP-blot analysis of activated
P38 MAPK in the adrenal gland (D). Lane 1, no stress; lane 2, stressed; lane 3, +YVAD-CHO; lane 4, +Z-FA-fmk; and lane 5, stressed cas-
pase-1 KO mice. Induction of IL-18 (panel 1), caspase-1 (panel 2), caspase-11 (panel 3), and activated P38 MAPK (4) in zona reticularis of the
cortex of the adrenal gland in stressed mice (E). Expression of activated P38 MAPK in the presence of caspase inhibitors. Z-FA-fmk (panel
1) and YVAD-CHO (panel 2) in stressed mice (F). *p < 0.05 and **p < 0.01 compared to control; #p < 0.01 and ##p < 0.001 to stressed; n = 6.
Data were presented as ± SD.Involvement of Superoxide in the Upregulation (
iof P38 MAPK
Reactive oxygen species have been shown to mediate s
pP38 MAPK phosphorylation in lung fibroblasts (Han et
al., 2003), neurtophils (Nick et al., 1997), and monocytes uGuha et al., 2000). We examined the effect of superox-
de-dismutase (SOD) on P38 MAPK phosphorylation in
tressed mice. SOD was found to inhibit P38 MAPK
hosphorylation about 70% in the adrenal gland (Fig-
re 4A).
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P38 MAPK Activation
Effect of SOD on levels of activated P38
MAPK protein (A), 43 kD procaspase-11 (B),
caspase-1 activity (C), plasma IL-18 (D), and
IL-18 precursor (E) in the adrenal gland. Ef-
fect of DPI, a NADPH oxidase inhibitor, on
IL-18 levels in plasma (F). *p < 0.01 and
**p < 0.001 to control; #p < 0.05 and ##p <
0.01 to stressed; n = 6. Data were presented
as ± SD.SOD also reduced levels of procaspase-11 (Figure
4B), caspase-1 activity (Figure 4C), and plasma IL-18
(Figure 4D), but not the adrenal pro-IL-18 (Figure 4E) in
stressed mice. Stress induction of plasma IL-18 was
inhibited by diphenyleneiodnium (DPI), a nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase in-
hibitor (Figure 4F), supporting the notion that superox-
ide anions are involved in stress induction of plasma IL-
18 via P38 MAPK phosphorylation. Similar results were
obtained with excised adrenal gland incubated with
paraquat (data not shown).
Involvement of IL-18 in the Regulation of Plasma
IL-6 Levels in Stressed Mice
The relationship between IL-18 and IL-6 was examined
by using IL-18-deficient mice. Without the stress, IL-6
was undetectable in wt and IL-18 KO mice, but after 3
hr of the immobilization stress, IL-6 levels reached 230
pg/ml in wt mice and 25 pg/ml in IL-18 KO mice (Figure
5A). After release from the stress, plasma IL-6 remained
at around 80 pg/ml in wt mice, whereas it decreased to
5 pg/ml in IL-18 KO mice (Figure 5A). Treatments with
YVAD-CHO, SOD, anti-IL-18 antibody, or anti-IL-18 re-
ceptor chains antibodies resulted in 70% inhibition of
stress-induced increases in plasma IL-6 levels in wt
mice (Figure 5B). These results showed that the stress
induces IL-6 in plasma in an IL-18-dependent manner.
Discussion
In this study, we showed that the acute immobilization
stress caused increases in 24 kD pro-IL-18 levels in the
adrenal gland and 18 kD mature IL-18 levels in plasma.
These increases were preceded by elevation of ACTH
levels in plasma, suggesting that ACTH is involved in
the elevation of pro and mature IL-18. This was sup-
ported by the finding that administration of anti-ACTH
antiserum or dexamethasone to block ACTH release re-
sulted in suppression of the increases in both pro and
mature IL-18 levels in stressed mice. These results indi-
cated that the immobilization stress induces ACTH,
which in turn induces pro-IL-18 in the adrenal gland.Figure 5. Stress Induction of IL-6 in Plasma Is IL-18 Dependent
(A) Plasma IL-6 levels in stressed wild-type (wt) and IL-18-defi-
cient mice.
(B) Effect of YVAD-CHO, a caspase-1 inhibitor, SOD, anti-IL-18 anti-
body, and anti-IL-18 receptor chains antibodies mixture (10 g
each) on plasma IL-6 levels in stressed wt mice. *p < 0.05 and
**p < 0.01 to control; #p < 0.05 and ##p < 0.01 to wt at each time
point; and +p < 0.01 and ++p < 0.001 to stressed wt; n = 6.
Data were presented as ± SD.
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pduced in the adrenal gland by lipopolysaccharide (LPS)
(Tingsborg et al., 1997). In this study, we showed that
athe immobilization stress also induces casapse-1 pre-
cursor and active caspase-1. YVAD-CHO blocked the s
pelevation of mature IL-18 in plasma, but not the induc-
tion of pro-IL-18 in the adrenal gland. In stressed cas- a
tpase-1 KO mice, plasma IL-18 was not detectable, al-
though pro-IL-18 protein was upregulated in the i
iadrenal gland (data not shown). These results indicated
that stress-induced caspase-1 is responsible for the P
oprocessing of pro-IL-18 in the adrenal gland and the
accumulation of mature IL-18 in plasma. b
iCaspase-11 has been shown to activate caspase-1
(Wang et al., 1998). In the present study, procaspase-
p11 was induced in the adrenal gland by the stress, and
the inhibitor of caspase-11 Z-FA-fmk and anti-caspase- l
w11 antibody blocked the activation of caspase-1 by the
stress, indicating the involvement of caspase-11 in cas- n
tpase-1 activation in stressed mice. In LPS-injected
mice, IL-18 and IFN-γ induction by LPS was sup- w
ppressed by caspase-11 inhibition (data not shown). To-
gether, it is suggested that caspase-11 is involved in p
aIL-18 conversion (activation) in stress as well as in en-
dotoxemia. t
We found that SB202190, a P38 MAPK inhibitor and
anti-phosphorylated-P38 MAPK antibody blocked the (
tstress-induced increases in procaspase-11 levels, cas-
pase-1 activity, and plasma IL-18 levels. PD98059, an i
bMEK inhibitor, showed no affection on the caspase-11
induction and lesser suppression on caspase-1 activity I
Yand IL-18 level than P38 MAPK inhibitors. YVAD-CHO,
the caspase-1 inhibitor, and Z-FA-fmk, the caspase-11 s
ainhibitor, suppressed stress-induced elevation of plasma
IL-18 levels without affecting phosphorylation of P38 s
1MAPK. Stress-induced phosphorylation of P38 MAPK
occurred in caspase-1 KO mice as well as in wt mice. s
bP38 MAPK, caspase-11, caspase-1, and pro-IL-18 pro-
teins were accumulated in an overlapping manner in 1
zona reticularis in the adrenal cortex, possibly forming
a caspase-1 activating pathway to affect conversion of f
apro-IL-18 in the adrenal gland to the mature form to
be released into plasma in stressed mice. P38 MAPK a
Iinvolvement in caspase-1 activation via caspase-11 is
demonstrated. On the other hand, PD 98059, a MEK s
minhibitor, showed lesser suppression on the caspase-1
activation and IL-18 rise than P38 MAPK inhibitors. i
ICombined treatment with Z-FA-fmk resulted in further
downregulation, suggesting an ERK1/2-mediated, cas- d
lpase-11-independent pathway for the stress-induced
caspase-1 activation. Recently, Guo et al. reported that s
tPD 98059 inhibited caspase-1 activation by Fas ligation
in dendritic cells, discussing the involvement of ERK1/2 c
i(Guo et al., 2003). Together, it is suggested that stress
activates caspase-1 mainly via P38 MAPK/caspase-11 t
land subsidiary via ERK1/2 pathways.
It has been reported that reactive oxygen species c
sparticipate in P38 MAPK activation (Guha et al., 2000;
Han et al., 2003; Nick et al., 1997). In the present study, o
pSOD inhibited the activation of P38 MAPK (Figure 4A),
induction of caspase-11, activation of caspase-1 in the s
adrenal gland, and the elevation of IL-18 levels in
plasma (Figures 4B–4D). However, induction of pro-IL- t
(18 in the adrenal gland was not affected by SOD (FigureE). These results suggest that the stress induces su-
eroxide anions, which activate the P38 MAPK cascade.
In our preliminary experiment using paraquat on the
drenal gland excised from ACTH administrated mice,
uperoxide-dependent P38 MAPK activation, procas-
ase-11 induction, upregulation of caspase-1 activity,
nd IL-18 conversion were observed. P38 MAPK inhibi-
ors, but not PD98059, suppressed the procaspase-11
nduction and subsequent events, and Z-FA-fmk inhib-
ted the upregulation of caspase-1 activation, but not
38 MAPK phosphorylation, suggesting that the super-
xide-induced caspase-1 activation is mainly mediated
y P38 MAPK and caspase-11 and that P38 MAPK is
nvolved in caspase-11 induction.
Thus, the process in which IL-18 is generated in
lasma in stressed mice may be summarized as fol-
ows: stress activates the HPA axis to induce ACTH,
hich induces pro-IL-18 and procaspase-1 in the adre-
al cortex. Stress also generates superoxide anions
hat induce P38 MAPK phosphorylation (Thr180/Tyr182),
hich induces caspase-11, which in turn activates cas-
ase-1. Independently, a ERK1/2 pathway subsidiary
articipates in caspase-1 activation. Caspase-1, thus
ctivated, converts pro-IL-18 in the adrenal gland into
he mature form, which is secreted into plasma.
IL-18 activates TLR2 (Blease et al., 2001) and MyD88
Adachi et al., 1998), which are required for IL-6 induc-
ion (Takeuchi et al., 2000), suggesting that IL-18 might
nduce IL-6. In this study, this possibility was supported
y the following results: (1) stress elevated plasma
L-6 levels in wt mice, but not in IL-18 KO mice, (2)
VAD-CHO, a caspase-1 inhibitor, or SOD blocked the
tress-induced elevation of IL-18 and IL-6 in plasma,
nd (3) anti-IL-18 antibody suppressed IL-6 levels in
tressed mice. In contrast, IL-18-deficient mice showed
0% reduction in IL-6 induction by LPS (data not
hown). Together, our results demonstrated that immo-
ilization stress elevates IL-6 levels in plasma in an IL-
8-dependent pathway.
Glucocorticoids (GCs) have negative and positive ef-
ects with a dynamic and bidirectional spectrum of
ctivities on immune response. Production of IFN-α
nd -γ, IL-12, and TNF-α is suppressed but that of
L-4, IL-10, and IL-13 is upregulated by GCs (for review,
ee Elenkov [2004]). GCs have also been reported to
odulate genes involved in the priming of the innate
mmunity response (for review, see Franchimont [2004]).
n the present study, dexamethasone inhibited the in-
uction of pro-IL-18 via the suppression of ACTH re-
ease (Figures 1B and 1C). Immobilization of mice re-
ulted in elevation of corticosterone levels in plasma
o about 400 pg/ml (data not shown), whereas IL-18
onversion via the caspase-1 pathway was maintained
n the adrenal gland, indicating that GCs do not inhibit
he caspase-1 activating pathway. When mice were re-
eased from the restrainer, corticosterone levels de-
lined, but IL-18 levels were sustained (data not
hown), likely due to a longer half-life of IL-18 than that
f GCs. It is suggested that IL-18 may act on cells
rimed by GCs and is involved in allo- and/or homeo-
tatic responses.
It has been reported that plasma IL-18 levels in pa-
ients with autoimmune and inflammatory diseases
Nakanishi et al., 2001a; Nakanishi et al., 2001b; Oka-
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675mura et al., 2003), including rheumatoid arthritis (RA)
(Walker et al., 1997), systemic lupus erythematosus
(Schubert et al., 1999), and multiple sclerosis (Zorzon
et al., 2001), are elevated after psychological and/or
physical stresses. In RA patients, neutrophil has been
shown to produce several cytokines, including TNF-α,
in response to IL-18 (Leung et al., 2001), suggesting
that IL-18 may activate inflammatory processes in au-
toimmune patients. Bossu et al. have reported that
IL-18 cDNA vaccination ameliorates spontaneous lu-
pus-like nephritis in MRL/lpr mice (Bossu et al., 2003),
indicating that IL-18 is involved in autoimmune pathol-
ogy. This raises the possibility that stress-induced ex-
acerbation of inflammatory and autoimmune diseases
may be suppressed by regulating levels of mature IL-18
and superoxide anions. Thus, controlling the caspase-1
cascade may serve as a means to prevent host-
defense disruption caused by psychological/physical
stressors.
Experimental Procedures
Animals
Male C57B6 mice were purchased from Seac Yoshitomi (Japan).
IL-18 KO mice (C57/B6 background) (Takeda et al., 1998), and cas-
pase-1 KO mice (Balb/C background) (Kuida et al., 1995) were
kindly provided by Dr. K. Takeda and Dr K. Kuida, respectively. Mice
were housed one per cage at 20°C. Experiments involving mice
were conducted starting at 10 a.m.
Chemicals and Reagents
Anti-ACTH antiserum was obtained from Progen Biotechnik, Hei-
delberg, Germany; anti-mouse IL-18 monoclonal antibody from
MBL, Japan; anti-mouse caspase-1 antibody (sc-515) from Santa
Cruz, USA; anti-mouse/rat caspase-11 antibody from BIOMOL,
USA; anti-phosphorylated (Thr180/Tyr182) P38 MAPK antibody
from Cell Signaling Technology, USA; anti-TNF-α antibody from
Alexis, USA; and normal rabbit IgG from Vector, UK. Affinity-purified
polyclonal IgGs against mouse IL-18 receptor α and β chains were
raised in rabbits inoculated with synthetic peptides of hydrophilic
sequences near the putative transmembrane domains of IL-18 re-
ceptor α chains (Parnet et al., 1996) and β chains (Born et al., 1998),
respectively. Synthetic ACTH (1–24 amino terminus) was purchased
from Peninsula Laboratories Inc. (USA). Ac-YVAD-CHO and Ac-
YVAD-MCA were purchased from Peptide Institute (Japan), Z-FA-
fmk and SB202190 from Calbiochem-Novabiochem (San Diego,
USA), and PD98059 (IC50 values are 1–20 µM for MAPK/ERK ki-
nase or MEK) from TOCRIS (UK). Diphenyleneiodonium chrolide
(DPI), a NADPH oxidase inhibitor and SOD were purchased from
Sigma (St. Louis, USA). Z-FA-fmk, which has been reported to show
affection on cathepsin B (Schotte et al., 2000), but not on caspases
(Sillence and Allan, 1997; McColl et al., 1998; Gregoli and Bon-
durant, 1999), was used as a cathepsin-B inhibitor, which in turn
results in selective suppression on caspase-11 (Schotte et al.,
2000). SB202190 was employed as a P38 MAPK inhibitor, which
binds with the ATP pocket of the active kinase to inhibit the P38 α
and β isoforms selectively (IC50 values are 50 and 100 nM for p38α/
SAPK2α and p38β2/SAPK2β, respectively [Frantz et al., 1998; Man-
they et al., 1998]).
Immobilization Stress
For the immobilization stress, mice were placed in a restrainer (a
rounded plastic tube 27 mm in diameter) for 1, 3, or 6 hr, and IL-18
levels were analyzed. For analysis of IL-6, mice were immobilized
as described above and then housed in the original cage for 6 hr
prior to assaying IL-6.
Assays of Cytokines
After the immobilization, mice were anesthetized with diethyl ether,
and blood was taken into EDTA-containing tubes. Plasma was sep-arated by centrifugation at 10,000 × g for 10 min. at 4°C and stored
at −80°C. IL-18 and IL-6 were analyzed by ELISA using Quantikine
immunoassay kit (R&D Systems) and OptEIA (BD-Pharmingen, CA,
USA), respectively.
Treatment with Anti-ACTH Antiserum, Dexamethasone,
ACTH, and Anti-IL-18 Antibody
Mice were intraperitonealy injected with anti-ACTH antiserum
(50 l, 1:1) or dexamethasone (1 ng/50l PBS[−]) or anti-IL-18 anti-
body (50 l, 1:1) and 10 min later placed in the immobilization tube
for 6 hr. Synthetic ACTH (250 g/50 l PBS[−]) was injected to the
left limb, and 6 hr later, mice were subjected to experiments.
Treatment with Caspase-1 Inhibitor, Caspase-11 Inhibitor,
P38 MAPK Inhibitors, Anti-Phosphorylated-P38 MAPK
Antibody, MEK Inhibitors, SOD, and DPI
Mice were placed in the restrainer for 1 hr and injected with Ac-
YVAD-CHO (200 M/50 l PBS[−]), Z-FA-fmk (100 M/50 l
PBS[−]), and SB202190 (2 g/50 l PBS[−] per mouse), PD98059
(20 g/50 l PBS[−] per mouse), anti-phosphorylated-P38 MAPK
antibody (2 l/50 l PBS[−] per mouse), anti-TNF-α antibody (4 l/
50 l PBS[−] per mouse), or normal rabbit IgG (4 l/50 l PBS[−]
per mouse) intraperitonealy. SOD (20 U) and DPI (30 g) were in-
jected into mice intraperitoneally 1 and 3 hr after the start of immo-
bilization.
Immunoprecipitation and Western Blotting
For Western blot analysis of IL-18 and phosphorylated P38 MAPK
in the adrenal tissue, the tissue was homogenized by a Polytron
homogenizer in immunoprecipitation (IP) buffer (50 mM Tris, [pH
7.4], 150 mM NaCl, 0.5% Nonidet P-40, and 0.5% sodium deoxy-
cholate) with a protease inhibitor mixture (Roche Diagnostics Ja-
pan). The homogenate (100 µg of proteins) was precleared by pro-
tein A/G agarose (Exalpha Biologicals, Inc., USA), incubated with
anti-mouse IL-18 monoclonal antibody (MBL) or anti-phosphory-
lated (Thr180/Tyr182) P38 MAPK antibody (Cell Signaling Tech-
nology) with the protein A/G agarose (50 µl), and centrifugated
(13,000 × g for 25 min., 4°C). The pellet was suspended in loading
buffer and boiled to retrieve adrenal proteins, electrophoresed in a
10%–20% SDS-polyacrylamide gradient gel, and electrotransferred
on Hybond ECL (Amersham) nitrocellulose membrane. Membranes
were incubated with antibody against IL-18 (MBL), phosphorylated
(Thr180/Tyr182) P38 MAPK (Cell Signaling Technology), caspase-1
(Santa Cruz, USA), or caspase-11 (BIOMOL, USA), and reacted pro-
teins were detected by ECL plus system (Amershan biosciences).
Procaspase-11 and activated P38 MAPK were quantified by using
the Science Lab 99 image-analysis system (Fujifilm, Japan).
Immunohistochemistry
Adrenal glands were formalin fixed, paraffin embedded, and cut to
4 m sections. They were incubated with antibodies to P38 MAPK,
caspase-11, caspase-1 (1:200 in all cases), or IL-18 (1:400). Horse-
radish peroxidase-conjugated secondary antibody (Santa Cruz,
USA) and diaminobenzidine were used to develop color. Sections
without primary antibody and sections from no-stressed mice were
employed as control.
Analysis of Caspase-1 Activity
Caspase-1 activity in the adrenal gland was measured by using a
caspase assay kit (BD-Pharmingen, CA, USA). In brief, adrenal tis-
sue homogenates were incubated with a caspase-1 fluorogenic
substrate, Ac-YVAD-AMC, and AMC liberated from Ac-YVAD-AMC
was measured by using a fluorometric plate reader with an excita-
tion wavelength of 380 nm and an emission wavelength of 420–
460 nm.
Statistical Analysis
All data were presented as the mean ± SD from at least three inde-
pendent experiments. Statistical comparisons between different
treatments were done by Student’s t test using the GraphPad Prism
program (GraphPad Software Inc., USA). p values less than 0.05
were considered statistically significant.
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